{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:51:10Z","timestamp":1787161870938,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["21-43"],"award-info":[{"award-number":["21-43"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007312","name":"National Center for Geriatrics and Gerontology","doi-asserted-by":"publisher","award":["22503"],"award-info":[{"award-number":["22503"]}],"id":[{"id":"10.13039\/501100007312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.bmcl.2023.129327","type":"journal-article","created":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T02:11:47Z","timestamp":1683943907000},"page":"129327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Development of a novel PET ligand, [11C]GO289 targeting CK2 expressed in the brain"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6474-6229","authenticated-orcid":false,"given":"Aya","family":"Ogata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ikenuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichiro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Ichise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Amaike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4876-3608","authenticated-orcid":false,"given":"Tsuyoshi","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Kakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Itami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7927-9483","authenticated-orcid":false,"given":"Yasuyuki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2023.129327_b0005","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.bmcl.2023.129327_b0010","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41583-018-0067-3","article-title":"Imaging the evolution and pathophysiology of Alzheimer disease","volume":"19","author":"Jagust","year":"2018","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bmcl.2023.129327_b0015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0006-8993(90)90282-G","article-title":"Aberrant casein kinase \u2161 in Alzheimer\u2019s disease","volume":"507","author":"Iimoto","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.bmcl.2023.129327_b0020","first-page":"10,7","article-title":"CK2-an emerging target for neurological and psychiatric disorders","author":"Castello","year":"2017","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bmcl.2023.129327_b0025","doi-asserted-by":"crossref","first-page":"14779","DOI":"10.1523\/JNEUROSCI.4161-09.2009","article-title":"CK2 is a novel negative regulator of NADPH oxidase and a neuroprotectant in mice after cerebral ischemia","volume":"29","author":"Kim","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.bmcl.2023.129327_b0030","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4049\/jimmunol.2101080","article-title":"Protein kinase CK2 Controls CD8+ T cell effector and memory function during infection","volume":"209","author":"Yang","year":"2022","journal-title":"J Immunol"},{"key":"10.1016\/j.bmcl.2023.129327_b0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11010-010-0667-3","article-title":"Treatment of cultured human astrocytes and vascular endothelial cells with protein kinase CK2 inhibitors induces early changes in cell shape and cytoskeleton","volume":"349","author":"Kramerov","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.bmcl.2023.129327_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-5793(91)80249-3","article-title":"The decreased level of casein kinase 2 in brain cortex of schizophrenic and Alzheimer\u2019s disease patients","volume":"279","author":"Aksenova","year":"1991","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bmcl.2023.129327_b0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/life13010147","article-title":"Phosphorylation and dephosphorylation of beta-amyloid peptide in model cell cultures: the role of cellular protein kinases and phosphatases","volume":"13","author":"Barykin","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.bmcl.2023.129327_b0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12974-015-0470-x","article-title":"Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer\u2019s disease pathology","volume":"13","author":"Rosenberger","year":"2016","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.bmcl.2023.129327_b0055","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fnmol.2018.00146","article-title":"CK2 phosphorylating I2PP2A\/SET mediates tau pathology and cognitive impairment","volume":"11","author":"Zhang","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.bmcl.2023.129327_b0060","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41392-021-00567-7","article-title":"Protein kinase CK2: a potential therapeutic target for diverse human diseases","volume":"6","author":"Borgo","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.bmcl.2023.129327_b0065","doi-asserted-by":"crossref","first-page":"eaau9060","DOI":"10.1126\/sciadv.aau9060","article-title":"Cell-based screen identifies a new potent and highly selective CK2 inhibitor for modulation of circadian rhythms and cancer cell growth","volume":"5","author":"Oshima","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.bmcl.2023.129327_b0070","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/cn100008c","article-title":"Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem Nerosci"},{"key":"10.1016\/j.bmcl.2023.129327_b0075","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1021\/jm101251q","article-title":"Discovery and SAR of 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer","volume":"54","author":"Pierre","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2023.129327_b0080","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1158\/0008-5472.CAN-10-1893","article-title":"CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy","volume":"70","author":"Siddiqui-Jain","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmcl.2023.129327_b0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11010-011-0963-6","article-title":"Predominance of CK2a over CK2a' in the mammalian brain","volume":"356","author":"Ceglia","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.bmcl.2023.129327_b0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/09680519990050011801","article-title":"Activation of protein kinase CK2 by LPS is mediated by the MAP kinase pathway","volume":"5","author":"Means","year":"1999","journal-title":"J Endotoxin Res"},{"key":"10.1016\/j.bmcl.2023.129327_b0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12974-015-0434-1","article-title":"Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit","volume":"12","author":"Banks","year":"2015","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.bmcl.2023.129327_b0100","article-title":"Blood-brain barrier disruption by lipopolysaccharide and sepsis-associated encephalopathy","volume":"11","author":"Peng","year":"2021","journal-title":"Front. Cell. Infect."},{"key":"10.1016\/j.bmcl.2023.129327_b0105","doi-asserted-by":"crossref","first-page":"e98143","DOI":"10.1371\/journal.pone.0098143","article-title":"Assessment of blood-brain barrier function and the neuroinflammatory response in the rat brain by using cerebral open flow microperfusion (cOFM)","volume":"9","author":"Ghosh","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bmcl.2023.129327_b0110","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1039\/D1OB00257K","article-title":"Chemical probes targeting the kinase CK2: a journey outside the catalytic box","volume":"19","author":"Iegre","year":"2021","journal-title":"Org Biomol Chem"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X23002056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X23002056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:48:25Z","timestamp":1760773705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X23002056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":22,"alternative-id":["S0960894X23002056"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2023.129327","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a novel PET ligand, [11C]GO289 targeting CK2 expressed in the brain","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2023.129327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"129327"}}